search
› › › The FDA has approved Spravato nasal spray to treat major depressive disorder
The FDA has approved Spravato nasal spray to treat major depressive disorder

The FDA has approved Spravato nasal spray to treat major depressive disorder

By Wednesday, March 6, 2019 Comment Edit

Spravato nasal spray, also known as esketamine, can now be used to treat depression in adults with treatment-resistant depression.

     
 
 


from USATODAY - News Top Stories https://ift.tt/2VIBHbh
via IFTTT

0 Response to "The FDA has approved Spravato nasal spray to treat major depressive disorder"

Post a Comment

Subscribe to: Post Comments (Atom)